Continuous Glucose Monitor
FreeStyle Libre 2
- 84/100 science score
- $65 price
Overview
FreeStyle Libre 2 excels in effectiveness (95/100) due to proven accuracy (MARD 9.3% in FDA pivotal n=285) and outcomes in 10+ RCTs/meta-analyses showing HbA1c reductions. Safety (65/100) tempered by post-market MAUDE events (736 injuries/7 deaths) despite clean pivotal trials. Quality (80/100) bolstered by FDA iCGM but lacks supp-style certs/COA. Overall 85/100 reflects reliable CGM for diabetes management at clinically validated performance.
Key strengths
- FDA iCGM cleared with MARD 9.2-9.3% in pivotal studies (n=285 participants)
- 10+ RCTs show improved HbA1c/TIR (e.g., 12-week pediatric RCT n=100)
- Cost-effective: $75-150/28 days (~$2.70-5.35/day) vs category avg $5-17/day
Our analysis
FreeStyle Libre 2 is an effective FDA-cleared CGM with strong RCT evidence (MARD 9.3%, n=285 pivotal; 10+ RCTs) for better glycemic control at low cost. Safety concerns from adhesive allergies and MAUDE malfunctions warrant monitoring. Excellent for diabetes management where tolerated.
Frequently asked questions
- Is FreeStyle Libre 2 worth buying?
- FreeStyle Libre 2 has a Verify Influencers trust score of 84/100 based on ingredient quality, clinical evidence, and third-party testing.
- What is the trust score for FreeStyle Libre 2?
- FreeStyle Libre 2 scored 84 out of 100 in our science-backed analysis, which evaluates ingredient dosages against clinical literature and manufacturing transparency.
Browse all scored products · How products are scored